ResearcherIntermountain Medical CenterNo recent work listed
George M. Cannon
Matched on ORCID iD 0000-0001-9724-8341; OpenAlex author ID A5002180065. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2017: 1 paper · 2018: 1 paper
Papers 2
- Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. Co-author DOI 10.1136/esmoopen-2017-000282↗
- Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer. Last author DOI 10.1002/cncr.30780↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Anna M. Torgeson · 2 shared papers, 2017–2018 · strength 0.17
- Paper Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. DOI 10.1136/esmoopen-2017-000282↗
- Paper Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced p… DOI 10.1002/cncr.30780↗
- Shane A. J. Lloyd · 2 shared papers, 2017–2018 · strength 0.17
- Paper Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. DOI 10.1136/esmoopen-2017-000282↗
- Paper Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced p… DOI 10.1002/cncr.30780↗
- Ignacio Garrido‐Laguna · 2 shared papers, 2017–2018 · strength 0.17
- Paper Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. DOI 10.1136/esmoopen-2017-000282↗
- Paper Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced p… DOI 10.1002/cncr.30780↗
- Courtney L. Scaife · 1 shared paper, 2018 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.